Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Chemists express...

    Chemists express inability to return banned drugs immediately

    Written by Geeta Sharma Sharma Published On 2016-03-17T16:13:37+05:30  |  Updated On 17 March 2016 4:13 PM IST
    Chemists express inability to return banned drugs immediately
    Mumbai:The All India Organization of Chemists and Druggists, have expressed inability in prompt return of banned fixed dose combination drugs in a statement to the Health Ministry.

    According to Economic Times the organization , a lobby group of 750,000 wholesalers and retail chemists, in a statement to the department of health has made it explicitly clear that the 'unpleasant action' would take at least a month for all to return the banned compositions; in most cases requiring shutting down of shops to return the stocks across supply chains.

    Through a March 10 gazette notification, the government had banned the sale of 344 fixed dose combination drugs. A fixed dose combination drug is a mix of two or more drugs in a single dose. Some reports quoting government sources suggest that a further set of 500 drugs may also face the ban soon.

    In a March 14 letter to K L Sharma, Joint Secretary, Ministry of Health and Family Welfare, the organization of chemists and druggists stated that the current situation wherein 5,000 drugs from the list of banned drugs were available in the market, it would be difficult to find the brands of molecules that would allow them to discontinue the sale of the present ones with immediate effect.

    The letter questioned the ministry about why the ' irrational' fixed dose combinations had in the first place been allowed by the licensing authority, to be sold to patients for the past several years. The letter was signed by JS Shinde, President , All India Organization of Chemists and Druggists, and Suresh Gupta, General Secretary

    Meanwhile, a PharmaTrac market research study shows the ban may wipe out Rs 3,049 crore worth of brands from the Indian market, or about 3.1% of total sales of Rs 98,042 crore, recorded till February.
    All India Organization of Chemists and DruggistsFixed Dose Combination DrugsJS Shinde President AIOCDK L Sharma Joint SecretaryMinistry of Health and Family WelfareSuresh Gupta General Secretary AIOCD

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok